Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Samara L. Potter

Biography

Samara L. Potter, MD, MBA, is a physician in the Division of Hematology, Oncology, and Bone Marrow Transplant, and the Director of Clinical Cancer Genomics Outreach at the Institute for Genomic Medicine and at Nationwide Children’s Hospital. She is also an Assistant Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Potter attended medical school at Baylor College of Medicine and business school at The Jesse H. Jones Graduate School of Business at Rice University. She completed her Pediatric residency and Pediatric Hematology/Oncology fellowship at Texas Children’s Hospital. She earned a certificate of added qualification in the Clinical Scientist Training Program at Baylor College of Medicine.

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Research

Dr. Potter’s research focuses on the implementation of clinical genomic testing and molecularly targeted therapies in the pediatric cancer setting. Her clinical interests include extracranial solid tumors and rare tumors of childhood. Publications

                  Scollon S, Eldomery MK, Reuther J, Lin FY, Potter SL, Desrosiers L, McClain KL, Smith V, Su JM, Venkatramani R, Hu J, Korchina V, Zarrin-Khameh N, Gibbs RA, Muzny DM, Eng C, Roy A, Parsons DW, Plon SE. Clinical and molecular features of pediatric cancer patients with Lynch syndrome. Pediatr Blood Cancer. 2022 Nov; 69: e29859.

                


                  Potter SL, Reuther J, Chandramohan R, Gandhi I, Hollingsworth F, Sayeed H, Voicu H, Kakkar N, Baksi KS, Sarabia SF, Lopez ME, Chelius DC, Athanassaki ID, Mahajan P, Venkatramani R, Quintanilla NM, Lopez-Terrada DH, Roy A, Parsons DW. Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma. Pediatr Blood Cancer. 2021 Jan; 68: e28741.

                


                  Fair D, Potter SL, Venkatramani R. Challenges and solutions to the study of rare childhood tumors. Curr Opin Pediatr. 2020 Feb; 32: 7-12.

                


                  Luckie TM, Potter SL, Bacino CA, Shah R, Heczey A, Venkatramani R. Agenesis of the corpus callosum and hepatoblastoma. Am J Med Genet A. 2020 Jan; 182: 224-228.

                


                  Potter SL, HaDuong J, Okcu F, Wu H, Chintagumpala M, Venkatramani R. Pediatric Bronchial Carcinoid Tumors: A Case Series and Review of the Literature. J Pediatr Hematol Oncol. 2019 Jan; 41: 67-70.

                


                  Potter SL, Quintanilla NM, Johnston DK, Naik-Mathuria B, Venkatramani R. Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab. Pediatr Blood Cancer. 2018 Oct; 65: e27291.

                


                  Potter SL, Venkatramani R, Wenderfer S, Graham BH, Vasudevan SA, Sher A, Wu H, Wheeler DA, Yang Y, Eng CM, Gibbs RA, Roy A, Plon SE, Parsons DW. Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemia. Pediatr Blood Cancer. 2017 May; 64:

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 01/01/2023

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Texas Children’s Hospital

Date Completed: 06/30/2017

Residency

Texas Children’s Hospital

Date Completed: 06/30/2014

Graduate School

Rice University

Date Completed: 05/31/2011

Medical School

Baylor College of Medicine

Date Completed: 05/01/2011

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Samara L. Potter

Biography

Samara L. Potter, MD, MBA, is a physician in the Division of Hematology, Oncology, and Bone Marrow Transplant, and the Director of Clinical Cancer Genomics Outreach at the Institute for Genomic Medicine and at Nationwide Children’s Hospital. She is also an Assistant Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Potter attended medical school at Baylor College of Medicine and business school at The Jesse H. Jones Graduate School of Business at Rice University. She completed her Pediatric residency and Pediatric Hematology/Oncology fellowship at Texas Children’s Hospital. She earned a certificate of added qualification in the Clinical Scientist Training Program at Baylor College of Medicine.

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Research

Dr. Potter’s research focuses on the implementation of clinical genomic testing and molecularly targeted therapies in the pediatric cancer setting. Her clinical interests include extracranial solid tumors and rare tumors of childhood. Publications

                  Scollon S, Eldomery MK, Reuther J, Lin FY, Potter SL, Desrosiers L, McClain KL, Smith V, Su JM, Venkatramani R, Hu J, Korchina V, Zarrin-Khameh N, Gibbs RA, Muzny DM, Eng C, Roy A, Parsons DW, Plon SE. Clinical and molecular features of pediatric cancer patients with Lynch syndrome. Pediatr Blood Cancer. 2022 Nov; 69: e29859.

                


                  Potter SL, Reuther J, Chandramohan R, Gandhi I, Hollingsworth F, Sayeed H, Voicu H, Kakkar N, Baksi KS, Sarabia SF, Lopez ME, Chelius DC, Athanassaki ID, Mahajan P, Venkatramani R, Quintanilla NM, Lopez-Terrada DH, Roy A, Parsons DW. Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma. Pediatr Blood Cancer. 2021 Jan; 68: e28741.

                


                  Fair D, Potter SL, Venkatramani R. Challenges and solutions to the study of rare childhood tumors. Curr Opin Pediatr. 2020 Feb; 32: 7-12.

                


                  Luckie TM, Potter SL, Bacino CA, Shah R, Heczey A, Venkatramani R. Agenesis of the corpus callosum and hepatoblastoma. Am J Med Genet A. 2020 Jan; 182: 224-228.

                


                  Potter SL, HaDuong J, Okcu F, Wu H, Chintagumpala M, Venkatramani R. Pediatric Bronchial Carcinoid Tumors: A Case Series and Review of the Literature. J Pediatr Hematol Oncol. 2019 Jan; 41: 67-70.

                


                  Potter SL, Quintanilla NM, Johnston DK, Naik-Mathuria B, Venkatramani R. Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab. Pediatr Blood Cancer. 2018 Oct; 65: e27291.

                


                  Potter SL, Venkatramani R, Wenderfer S, Graham BH, Vasudevan SA, Sher A, Wu H, Wheeler DA, Yang Y, Eng CM, Gibbs RA, Roy A, Plon SE, Parsons DW. Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemia. Pediatr Blood Cancer. 2017 May; 64:

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 01/01/2023

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Texas Children’s Hospital

Date Completed: 06/30/2017

Residency

Texas Children’s Hospital

Date Completed: 06/30/2014

Graduate School

Rice University

Date Completed: 05/31/2011

Medical School

Baylor College of Medicine

Date Completed: 05/01/2011

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Samara L. Potter

Contact Information

  • Call us at:
  • (614) 722-3550
  • Fax us at:
  • (614) 722-3369
  • PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Samara L. Potter

Biography

Samara L. Potter, MD, MBA, is a physician in the Division of Hematology, Oncology, and Bone Marrow Transplant, and the Director of Clinical Cancer Genomics Outreach at the Institute for Genomic Medicine and at Nationwide Children’s Hospital. She is also an Assistant Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Potter attended medical school at Baylor College of Medicine and business school at The Jesse H. Jones Graduate School of Business at Rice University. She completed her Pediatric residency and Pediatric Hematology/Oncology fellowship at Texas Children’s Hospital. She earned a certificate of added qualification in the Clinical Scientist Training Program at Baylor College of Medicine.

Biography

Samara L. Potter, MD, MBA, is a physician in the Division of Hematology, Oncology, and Bone Marrow Transplant, and the Director of Clinical Cancer Genomics Outreach at the Institute for Genomic Medicine and at Nationwide Children’s Hospital. She is also an Assistant Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Potter attended medical school at Baylor College of Medicine and business school at The Jesse H. Jones Graduate School of Business at Rice University. She completed her Pediatric residency and Pediatric Hematology/Oncology fellowship at Texas Children’s Hospital. She earned a certificate of added qualification in the Clinical Scientist Training Program at Baylor College of Medicine.

Biography

Samara L. Potter, MD, MBA, is a physician in the Division of Hematology, Oncology, and Bone Marrow Transplant, and the Director of Clinical Cancer Genomics Outreach at the Institute for Genomic Medicine and at Nationwide Children’s Hospital. She is also an Assistant Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Potter attended medical school at Baylor College of Medicine and business school at The Jesse H. Jones Graduate School of Business at Rice University. She completed her Pediatric residency and Pediatric Hematology/Oncology fellowship at Texas Children’s Hospital. She earned a certificate of added qualification in the Clinical Scientist Training Program at Baylor College of Medicine.

Samara L. Potter, MD, MBA, is a physician in the Division of Hematology, Oncology, and Bone Marrow Transplant, and the Director of Clinical Cancer Genomics Outreach at the Institute for Genomic Medicine and at Nationwide Children’s Hospital. She is also an Assistant Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Potter attended medical school at Baylor College of Medicine and business school at The Jesse H. Jones Graduate School of Business at Rice University. She completed her Pediatric residency and Pediatric Hematology/Oncology fellowship at Texas Children’s Hospital. She earned a certificate of added qualification in the Clinical Scientist Training Program at Baylor College of Medicine.

Samara L. Potter, MD, MBA, is a physician in the Division of Hematology, Oncology, and Bone Marrow Transplant, and the Director of Clinical Cancer Genomics Outreach at the Institute for Genomic Medicine and at Nationwide Children’s Hospital. She is also an Assistant Professor of Pediatrics at The Ohio State University College of Medicine.

Dr. Potter attended medical school at Baylor College of Medicine and business school at The Jesse H. Jones Graduate School of Business at Rice University. She completed her Pediatric residency and Pediatric Hematology/Oncology fellowship at Texas Children’s Hospital. She earned a certificate of added qualification in the Clinical Scientist Training Program at Baylor College of Medicine.

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Hematology/Oncology & BMT

Physician Team

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

  • Hematology/Oncology & BMT
  • Physician Team
  • Primary Department
  • Pediatrics
  • Primary Section
  • Hematology & Oncology

Research

Dr. Potter’s research focuses on the implementation of clinical genomic testing and molecularly targeted therapies in the pediatric cancer setting. Her clinical interests include extracranial solid tumors and rare tumors of childhood. Publications

                  Scollon S, Eldomery MK, Reuther J, Lin FY, Potter SL, Desrosiers L, McClain KL, Smith V, Su JM, Venkatramani R, Hu J, Korchina V, Zarrin-Khameh N, Gibbs RA, Muzny DM, Eng C, Roy A, Parsons DW, Plon SE. Clinical and molecular features of pediatric cancer patients with Lynch syndrome. Pediatr Blood Cancer. 2022 Nov; 69: e29859.

                


                  Potter SL, Reuther J, Chandramohan R, Gandhi I, Hollingsworth F, Sayeed H, Voicu H, Kakkar N, Baksi KS, Sarabia SF, Lopez ME, Chelius DC, Athanassaki ID, Mahajan P, Venkatramani R, Quintanilla NM, Lopez-Terrada DH, Roy A, Parsons DW. Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma. Pediatr Blood Cancer. 2021 Jan; 68: e28741.

                


                  Fair D, Potter SL, Venkatramani R. Challenges and solutions to the study of rare childhood tumors. Curr Opin Pediatr. 2020 Feb; 32: 7-12.

                


                  Luckie TM, Potter SL, Bacino CA, Shah R, Heczey A, Venkatramani R. Agenesis of the corpus callosum and hepatoblastoma. Am J Med Genet A. 2020 Jan; 182: 224-228.

                


                  Potter SL, HaDuong J, Okcu F, Wu H, Chintagumpala M, Venkatramani R. Pediatric Bronchial Carcinoid Tumors: A Case Series and Review of the Literature. J Pediatr Hematol Oncol. 2019 Jan; 41: 67-70.

                


                  Potter SL, Quintanilla NM, Johnston DK, Naik-Mathuria B, Venkatramani R. Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab. Pediatr Blood Cancer. 2018 Oct; 65: e27291.

                


                  Potter SL, Venkatramani R, Wenderfer S, Graham BH, Vasudevan SA, Sher A, Wu H, Wheeler DA, Yang Y, Eng CM, Gibbs RA, Roy A, Plon SE, Parsons DW. Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemia. Pediatr Blood Cancer. 2017 May; 64:

View More Publications

Research

Dr. Potter’s research focuses on the implementation of clinical genomic testing and molecularly targeted therapies in the pediatric cancer setting. Her clinical interests include extracranial solid tumors and rare tumors of childhood. Publications

                  Scollon S, Eldomery MK, Reuther J, Lin FY, Potter SL, Desrosiers L, McClain KL, Smith V, Su JM, Venkatramani R, Hu J, Korchina V, Zarrin-Khameh N, Gibbs RA, Muzny DM, Eng C, Roy A, Parsons DW, Plon SE. Clinical and molecular features of pediatric cancer patients with Lynch syndrome. Pediatr Blood Cancer. 2022 Nov; 69: e29859.

                


                  Potter SL, Reuther J, Chandramohan R, Gandhi I, Hollingsworth F, Sayeed H, Voicu H, Kakkar N, Baksi KS, Sarabia SF, Lopez ME, Chelius DC, Athanassaki ID, Mahajan P, Venkatramani R, Quintanilla NM, Lopez-Terrada DH, Roy A, Parsons DW. Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma. Pediatr Blood Cancer. 2021 Jan; 68: e28741.

                


                  Fair D, Potter SL, Venkatramani R. Challenges and solutions to the study of rare childhood tumors. Curr Opin Pediatr. 2020 Feb; 32: 7-12.

                


                  Luckie TM, Potter SL, Bacino CA, Shah R, Heczey A, Venkatramani R. Agenesis of the corpus callosum and hepatoblastoma. Am J Med Genet A. 2020 Jan; 182: 224-228.

                


                  Potter SL, HaDuong J, Okcu F, Wu H, Chintagumpala M, Venkatramani R. Pediatric Bronchial Carcinoid Tumors: A Case Series and Review of the Literature. J Pediatr Hematol Oncol. 2019 Jan; 41: 67-70.

                


                  Potter SL, Quintanilla NM, Johnston DK, Naik-Mathuria B, Venkatramani R. Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab. Pediatr Blood Cancer. 2018 Oct; 65: e27291.

                


                  Potter SL, Venkatramani R, Wenderfer S, Graham BH, Vasudevan SA, Sher A, Wu H, Wheeler DA, Yang Y, Eng CM, Gibbs RA, Roy A, Plon SE, Parsons DW. Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemia. Pediatr Blood Cancer. 2017 May; 64:

View More Publications

Research

Dr. Potter’s research focuses on the implementation of clinical genomic testing and molecularly targeted therapies in the pediatric cancer setting. Her clinical interests include extracranial solid tumors and rare tumors of childhood. Publications

                  Scollon S, Eldomery MK, Reuther J, Lin FY, Potter SL, Desrosiers L, McClain KL, Smith V, Su JM, Venkatramani R, Hu J, Korchina V, Zarrin-Khameh N, Gibbs RA, Muzny DM, Eng C, Roy A, Parsons DW, Plon SE. Clinical and molecular features of pediatric cancer patients with Lynch syndrome. Pediatr Blood Cancer. 2022 Nov; 69: e29859.

                


                  Potter SL, Reuther J, Chandramohan R, Gandhi I, Hollingsworth F, Sayeed H, Voicu H, Kakkar N, Baksi KS, Sarabia SF, Lopez ME, Chelius DC, Athanassaki ID, Mahajan P, Venkatramani R, Quintanilla NM, Lopez-Terrada DH, Roy A, Parsons DW. Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma. Pediatr Blood Cancer. 2021 Jan; 68: e28741.

                


                  Fair D, Potter SL, Venkatramani R. Challenges and solutions to the study of rare childhood tumors. Curr Opin Pediatr. 2020 Feb; 32: 7-12.

                


                  Luckie TM, Potter SL, Bacino CA, Shah R, Heczey A, Venkatramani R. Agenesis of the corpus callosum and hepatoblastoma. Am J Med Genet A. 2020 Jan; 182: 224-228.

                


                  Potter SL, HaDuong J, Okcu F, Wu H, Chintagumpala M, Venkatramani R. Pediatric Bronchial Carcinoid Tumors: A Case Series and Review of the Literature. J Pediatr Hematol Oncol. 2019 Jan; 41: 67-70.

                


                  Potter SL, Quintanilla NM, Johnston DK, Naik-Mathuria B, Venkatramani R. Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab. Pediatr Blood Cancer. 2018 Oct; 65: e27291.

                


                  Potter SL, Venkatramani R, Wenderfer S, Graham BH, Vasudevan SA, Sher A, Wu H, Wheeler DA, Yang Y, Eng CM, Gibbs RA, Roy A, Plon SE, Parsons DW. Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemia. Pediatr Blood Cancer. 2017 May; 64:

View More Publications

Dr. Potter’s research focuses on the implementation of clinical genomic testing and molecularly targeted therapies in the pediatric cancer setting. Her clinical interests include extracranial solid tumors and rare tumors of childhood. Publications

                  Scollon S, Eldomery MK, Reuther J, Lin FY, Potter SL, Desrosiers L, McClain KL, Smith V, Su JM, Venkatramani R, Hu J, Korchina V, Zarrin-Khameh N, Gibbs RA, Muzny DM, Eng C, Roy A, Parsons DW, Plon SE. Clinical and molecular features of pediatric cancer patients with Lynch syndrome. Pediatr Blood Cancer. 2022 Nov; 69: e29859.

                


                  Potter SL, Reuther J, Chandramohan R, Gandhi I, Hollingsworth F, Sayeed H, Voicu H, Kakkar N, Baksi KS, Sarabia SF, Lopez ME, Chelius DC, Athanassaki ID, Mahajan P, Venkatramani R, Quintanilla NM, Lopez-Terrada DH, Roy A, Parsons DW. Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma. Pediatr Blood Cancer. 2021 Jan; 68: e28741.

                


                  Fair D, Potter SL, Venkatramani R. Challenges and solutions to the study of rare childhood tumors. Curr Opin Pediatr. 2020 Feb; 32: 7-12.

                


                  Luckie TM, Potter SL, Bacino CA, Shah R, Heczey A, Venkatramani R. Agenesis of the corpus callosum and hepatoblastoma. Am J Med Genet A. 2020 Jan; 182: 224-228.

                


                  Potter SL, HaDuong J, Okcu F, Wu H, Chintagumpala M, Venkatramani R. Pediatric Bronchial Carcinoid Tumors: A Case Series and Review of the Literature. J Pediatr Hematol Oncol. 2019 Jan; 41: 67-70.

                


                  Potter SL, Quintanilla NM, Johnston DK, Naik-Mathuria B, Venkatramani R. Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab. Pediatr Blood Cancer. 2018 Oct; 65: e27291.

                


                  Potter SL, Venkatramani R, Wenderfer S, Graham BH, Vasudevan SA, Sher A, Wu H, Wheeler DA, Yang Y, Eng CM, Gibbs RA, Roy A, Plon SE, Parsons DW. Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemia. Pediatr Blood Cancer. 2017 May; 64:

View More Publications

Dr. Potter’s research focuses on the implementation of clinical genomic testing and molecularly targeted therapies in the pediatric cancer setting. Her clinical interests include extracranial solid tumors and rare tumors of childhood.

                  Scollon S, Eldomery MK, Reuther J, Lin FY, Potter SL, Desrosiers L, McClain KL, Smith V, Su JM, Venkatramani R, Hu J, Korchina V, Zarrin-Khameh N, Gibbs RA, Muzny DM, Eng C, Roy A, Parsons DW, Plon SE. Clinical and molecular features of pediatric cancer patients with Lynch syndrome. Pediatr Blood Cancer. 2022 Nov; 69: e29859.

                


                  Potter SL, Reuther J, Chandramohan R, Gandhi I, Hollingsworth F, Sayeed H, Voicu H, Kakkar N, Baksi KS, Sarabia SF, Lopez ME, Chelius DC, Athanassaki ID, Mahajan P, Venkatramani R, Quintanilla NM, Lopez-Terrada DH, Roy A, Parsons DW. Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma. Pediatr Blood Cancer. 2021 Jan; 68: e28741.

                


                  Fair D, Potter SL, Venkatramani R. Challenges and solutions to the study of rare childhood tumors. Curr Opin Pediatr. 2020 Feb; 32: 7-12.

                


                  Luckie TM, Potter SL, Bacino CA, Shah R, Heczey A, Venkatramani R. Agenesis of the corpus callosum and hepatoblastoma. Am J Med Genet A. 2020 Jan; 182: 224-228.

                


                  Potter SL, HaDuong J, Okcu F, Wu H, Chintagumpala M, Venkatramani R. Pediatric Bronchial Carcinoid Tumors: A Case Series and Review of the Literature. J Pediatr Hematol Oncol. 2019 Jan; 41: 67-70.

                


                  Potter SL, Quintanilla NM, Johnston DK, Naik-Mathuria B, Venkatramani R. Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab. Pediatr Blood Cancer. 2018 Oct; 65: e27291.

                


                  Potter SL, Venkatramani R, Wenderfer S, Graham BH, Vasudevan SA, Sher A, Wu H, Wheeler DA, Yang Y, Eng CM, Gibbs RA, Roy A, Plon SE, Parsons DW. Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemia. Pediatr Blood Cancer. 2017 May; 64:

View More Publications

  • Scollon S, Eldomery MK, Reuther J, Lin FY, Potter SL, Desrosiers L, McClain KL, Smith V, Su JM, Venkatramani R, Hu J, Korchina V, Zarrin-Khameh N, Gibbs RA, Muzny DM, Eng C, Roy A, Parsons DW, Plon SE. Clinical and molecular features of pediatric cancer patients with Lynch syndrome. Pediatr Blood Cancer. 2022 Nov; 69: e29859.
  • Potter SL, Reuther J, Chandramohan R, Gandhi I, Hollingsworth F, Sayeed H, Voicu H, Kakkar N, Baksi KS, Sarabia SF, Lopez ME, Chelius DC, Athanassaki ID, Mahajan P, Venkatramani R, Quintanilla NM, Lopez-Terrada DH, Roy A, Parsons DW. Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma. Pediatr Blood Cancer. 2021 Jan; 68: e28741.
  • Fair D, Potter SL, Venkatramani R. Challenges and solutions to the study of rare childhood tumors. Curr Opin Pediatr. 2020 Feb; 32: 7-12.
  • Luckie TM, Potter SL, Bacino CA, Shah R, Heczey A, Venkatramani R. Agenesis of the corpus callosum and hepatoblastoma. Am J Med Genet A. 2020 Jan; 182: 224-228.
  • Potter SL, HaDuong J, Okcu F, Wu H, Chintagumpala M, Venkatramani R. Pediatric Bronchial Carcinoid Tumors: A Case Series and Review of the Literature. J Pediatr Hematol Oncol. 2019 Jan; 41: 67-70.
  • Potter SL, Quintanilla NM, Johnston DK, Naik-Mathuria B, Venkatramani R. Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab. Pediatr Blood Cancer. 2018 Oct; 65: e27291.
  • Potter SL, Venkatramani R, Wenderfer S, Graham BH, Vasudevan SA, Sher A, Wu H, Wheeler DA, Yang Y, Eng CM, Gibbs RA, Roy A, Plon SE, Parsons DW. Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemia. Pediatr Blood Cancer. 2017 May; 64:

Education

Date of Appointment at Nationwide Children’s Hospital: 01/01/2023

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Texas Children’s Hospital

Date Completed: 06/30/2017

Residency

Texas Children’s Hospital

Date Completed: 06/30/2014

Graduate School

Rice University

Date Completed: 05/31/2011

Medical School

Baylor College of Medicine

Date Completed: 05/01/2011

Education

Date of Appointment at Nationwide Children’s Hospital: 01/01/2023

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Texas Children’s Hospital

Date Completed: 06/30/2017

Residency

Texas Children’s Hospital

Date Completed: 06/30/2014

Graduate School

Rice University

Date Completed: 05/31/2011

Medical School

Baylor College of Medicine

Date Completed: 05/01/2011

Education

Date of Appointment at Nationwide Children’s Hospital: 01/01/2023

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Texas Children’s Hospital

Date Completed: 06/30/2017

Residency

Texas Children’s Hospital

Date Completed: 06/30/2014

Graduate School

Rice University

Date Completed: 05/31/2011

Medical School

Baylor College of Medicine

Date Completed: 05/01/2011

Date of Appointment at Nationwide Children’s Hospital: 01/01/2023

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Texas Children’s Hospital

Date Completed: 06/30/2017

Residency

Texas Children’s Hospital

Date Completed: 06/30/2014

Graduate School

Rice University

Date Completed: 05/31/2011

Medical School

Baylor College of Medicine

Date Completed: 05/01/2011

Date of Appointment at Nationwide Children’s Hospital: 01/01/2023

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Texas Children’s Hospital

Date Completed: 06/30/2017

Residency

Texas Children’s Hospital

Date Completed: 06/30/2014

Graduate School

Rice University

Date Completed: 05/31/2011

Medical School

Baylor College of Medicine

Date Completed: 05/01/2011

  • Pediatric Hematology Oncology
  • Pediatrics

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
  • Call us at:
  • (614) 722-3550
  • Fax us at:
  • (614) 722-3369
  • Hematology & Oncology700 Children’s DrColumbus, OH 43205 (map)